相关实验视频

Updated: Mar 15, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

精确的CRISPR/Cas9和Cas12校正使用视网膜模型中的脂质复合物,这些模型来自患有遗传视网膜变症的患者

Laura Siles¹, Sheila Ruiz-Nogales¹, Pilar Méndez-Vendrell¹

¹Departament de Genètica, Institut de Microcirurgia Ocular, IMO Grupo Miranza, 08035 Barcelona, Spain.

|March 14, 2026

概括

使用CRISPR/Cas技术的基因编辑精确地纠正了来自患者的视网膜细胞中引起疾病的突变. 这为治疗遗传性视网膜变症提供了一个有希望的策略.

科学领域:

* 分子生物学 * 分子生物学
* 遗传学在遗传学方面
* 眼科眼科眼科

背景情况:

*CRISPR/Cas基因编辑显示出治疗罕见遗传疾病的潜力,例如遗传性视网膜变.
* 在提供CRISPR/Cas组件和在分化细胞中实现高效的同质导向修复 (HDR) 方面仍然存在挑战.

研究的目的:

* 通过患者衍生的诱导多能干细胞 (hiPSCs) 通过脂质复合体研究CRISPR/Cas9和Cas12核酶的传递,用于治疗Stargardt和Best疾病.
*为了评估基因编辑效率,DNA裂变和基于hiPSC的视网膜色素表皮质 (RPE) 和视网膜器官中的基于HDR的校正.

主要方法:

*使用了来自Stargardt病 (ABCA4变种) 和Best病 (BEST1变种) 的患者的hiPSC.
*使用脂质复合物传递CRISPR/Cas9和Cas12核酶,并与hiPSC衍生的RPE和视网膜器官中的电穿孔进行比较.
*评估了转染效率,sgRNA介导的DNA裂变和HDR校正率.

主要成果:

* 在hiPSC衍生的RPE细胞中实现了致病性BEST1变异的精确修复,Cas12显示了超过10%的HDR效率.
* 编辑后的RPE细胞保持了正常的形态和表达了关键的成熟度标记.
*视网膜有机体显示出有限的传染和没有可检测的DNA裂变,表明需要在复杂组织中进行优化.

结论:

*在患者衍生的RPE中,经过精确的,单核酸突变校正,使用脂积递送的CRISPR/Cas9和Cas12.
* 建立了基于CRISPR/Cas的治疗策略的概念验证,用于遗传性视网膜变.
*强调了基因编辑在治疗视网膜疾病中的临床翻译潜力.

关键词:

在ABCA4A4A4A4A4A4A4A4A4 最好的一个是BEST1.最好的疾病是疾病.克里斯普尔是什么意思?克里斯普尔是什么意思?斯塔格尔特病是斯塔格尔特病的一种疾病.基因编辑基因编辑遗传的视网膜变症脂质复杂症 (Lipoplex) 是一种表情.视网膜有机物视网膜有机物视网膜色素表皮质是视网膜色素表皮质.

更多相关视频

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...